SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001740
Filing Date
2021-09-09
Accepted
2021-09-09 16:16:36
Documents
50
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rlyb-20210630.htm   iXBRL 10-Q 2377603
2 EX-31.1 rlyb-20210630ex31_1.htm EX-31.1 19179
3 EX-31.2 rlyb-20210630ex31_2.htm EX-31.2 19410
4 EX-32.1 rlyb-20210630ex32_1.htm EX-32.1 11119
5 EX-32.2 rlyb-20210630ex32_2.htm EX-32.2 11118
6 GRAPHIC img113854762_0.jpg GRAPHIC 66963
  Complete submission text file 0000950170-21-001740.txt   5996954

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rlyb-20210630_cal.xml EX-101.CAL 24858
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20210630.xsd EX-101.SCH 32266
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20210630_lab.xml EX-101.LAB 287008
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rlyb-20210630_def.xml EX-101.DEF 150310
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20210630_pre.xml EX-101.PRE 219933
12 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20210630_htm.xml XML 734132
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

IRS No.: 851083789 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40693 | Film No.: 211244592
SIC: 2834 Pharmaceutical Preparations